Organon & Co. Price Today
Organon & Co.
OGN
Healthcare
$4.31B
💰
Market Cap
5.5
💸
Price to Earnings
$3.1
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Hold Consensus
Buy |
7 |
Strong Buy |
1 |
Hold |
4 |
Sell |
1 |
Strong Sell |
0 |
OGN Price Forecast Target
16.9 👉 43.0 +155%
OGN EPS Forecast
3.1 👉 4.6 +49%
Financials
Profit Margin
12 %
Revenue Growth
1.5 %
Dividend
$ 1.12
Held Percent
0.1% - Insiders
79.8% - Institutions
20.1% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $659.0M
-
💰 Blackrock Inc. $338.1M
-
💰 Mawer Investment Management Ltd. $274.6M
-
💰 State Street Corporation $271.5M
-
💰 Massachusetts Financial Services Co. $184.0M
Stock Ideas
Ron Baron Portfolio
Ron Baron is an American billionaire investor, entrepreneur, and the founder of Baron Capital Group, a well-known investment management firm. He is recognized for his long-term, growth-oriented investment approach and has built a successful track re…
Warren Buffet Portfolio
Invest like the oracle himself! View the stocks that Warren Buffett holds in the Berkshire Hathaway portfolio.
Scott Ferguson Portfolio
With a strong background as a protégé of Bill Ackman, founder of Pershing Square Capital Management, Scott Ferguson has honed his skills and expertise in the art of activist investing. He possesses the ability to identify undervalued companies with …
Chase Coleman Portfolio
Chase Coleman, the young and accomplished founder of Tiger Global, has made a significant impact in the investment world. With initial funding from Julian Robertson, Coleman's Tiger Global Management delivered impressive returns, including a remarka…📮FAQ
Some Frequently Asked Questions.
The Organon & Co. industry is Drug Manufacturers—General
The Organon & Co. sector is Healthcare
The Organon & Co. forecasted predicted Price to Earnings PE ratio is 3.7
The Organon & Co. Price to Earnings PE ratio is 5.5
The Market Capitalization of Organon & Co. is $4.31B
There are total of 255164523 float shares with 79.8% held by Institutions and 0.1% held by insiders
The MOrganon & Co. forecasted Earnings per Share EPS is $4.6
The Organon & Co. Earnings per Share EPS is 3.1
The Organon & Co. company has $3889000000 gross profits with 12 profit margins
The Organon & Co. Earnings Growth is 0.03% with 0.034% quarterly earnings growth
The Organon & Co. Revenue is $6168000000 with 0.015 revenue growth
The price target for Organon & Co. stock is $43.0 for the high target and $19.0 for the low target
The consensus analyst recommendations for Organon & Co. is Hold, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Organon & Co. is Hold, with the following breakdown:
- Buy: 7
- Strong Buy: 1
- Hold: 4
- Sell: 1
- Strong Sell: 0
The Beta of Organon & Co. is 0.9
The dividend of Organon & Co. is $1.12
The dividend yield of Organon & Co. is 0.0647%
The biggest institutional and mutual fund holders of Organon & Co. stock are
- Vanguard Group Inc
- Blackrock Inc.
- Mawer Investment Management Ltd.
- State Street Corporation
The Organon & Co. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0